ENTITY
Zai Lab Ltd

Zai Lab Ltd (ZLAB US)

131
Analysis
Health CareChina
Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.
more
Refresh
21 Oct 2020 09:40

GDS Holdings Hong Kong Secondary - Going Big. Will Almost Become Net Cash, for a While.

Gds Holdings (Adr) (GDS US) plans to raise around US$1.6bn in its secondary listing in Hong Kong. I had covered the background of the deal in my...

Logo
283 Views
Share
14 Oct 2020 16:24

GDS Holdings Hong Kong Secondary - Hot Sector, Needs the Money

Gds Holdings (Adr) (GDS US) plans to raise around US$1bn in its secondary listing in Hong Kong. Media reports indicate that the deal could be...

Logo
378 Views
Share
04 Oct 2020 12:46

ECM Weekly (4 October 2020) - JD Health, MINISO, Everest Med, Weihai Comm Bank, JD Digits

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...

Share
28 Sep 2020 10:43

ZTO Express Secondary Trading - Insti Little Weaker, Retail Little Stronger but Doing Well so Far

ZTO Express (ZTO US) plans to raise around US$1.4bn in its secondary listing in Hong Kong. While the company filed its PHIP on Friday, 11th Sep...

Logo
232 Views
Share
x